Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (GEINOCANN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03529448
Recruitment Status : Not yet recruiting
First Posted : May 18, 2018
Last Update Posted : May 31, 2019
Sponsor:
Collaborators:
Medical Cannabis Bike Tour
Voices Against Brain Cancer
Tilray
Information provided by (Responsible Party):
Grupo Español de Investigación en Neurooncología

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020